Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold A, Molin G (1998) The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 85(1):88–94

CAS  PubMed  Google Scholar 

Ali H, AbdelMageed M, Olsson L, Israelsson A, Lindmark G, Hammarström M-L, Hammarström S, Sitohy B (2019) Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer. Tumor Biology 41(6):1010428319858885

CAS  PubMed  Google Scholar 

Aminzadeh F, Ghorashi Z, Nabati S, Ghasemshirazi M, Arababadi MK, Shamsizadeh A, Karimabad MN, Khorramdelazad H, Darakhshan S, Hassanshahi G (2012) Differential Expression of CXC Chemokines CXCL 10 and CXCL 12 in Term and Pre-term Neonates and Their Mothers. Am J Reprod Immunol 68(4):338–344

CAS  PubMed  Google Scholar 

Amir NABM, Mackenzie AE, Jenkins L, Boustani K, Hillier MC, Tsuchiya T, Milligan G, Pease JE (2018) Evidence for the existence of a CXCL17 receptor distinct from GPR35. J Immunol 201(2):714–724

Google Scholar 

Avvari S, Prasad D, Khan IA (2022) Role of MicroRNAs in cell growth proliferation and tumorigenesis. Role of MicroRNAs in Cancers. Springer, pp 37–51

Azin H, Vazirinejad R, Ahmadabadi BN, Khorramdelazad H, Zarandi ER, Arababadi MK, Karimabad MN, Shamsizadeh A, Rafatpanah H, Hassanshahi G (2012) The SDF-1 3′ a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. J Mol Neurosci 47(3):431–436

CAS  PubMed  Google Scholar 

Behfar S, Hassanshahi G, Nazari A, Khorramdelazad H (2018) A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine 110:226–231

CAS  PubMed  Google Scholar 

Bottomley MJ, Thomson J, Harwood C, Leigh I (2019) The role of the immune system in cutaneous squamous cell carcinoma. Int J Mol Sci 20(8): 2009

Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16):3029–3030

PubMed  Google Scholar 

Burkhardt AM, Maravillas-Montero JL, Carnevale CD, Vilches-Cisneros N, Flores JP, Hevezi PA, Zlotnik A (2014) CXCL17 is a major chemotactic factor for lung macrophages. J Immunol 193(3):1468–1474

CAS  PubMed  Google Scholar 

Burkhardt AM, Tai KP, Flores-Guiterrez JP, Vilches-Cisneros N, Kamdar K, Barbosa-Quintana O, Valle-Rios R, Hevezi PA, Zuñiga J, Selman M (2012) CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol 188(12):6399–6406

CAS  PubMed  Google Scholar 

Cameron MJ, Kelvin DJ (2003) Cytokines and chemokines-their receptors and their genes: an overview. Adv Exp Med Biol 520:8–32

CAS  PubMed  Google Scholar 

Choi SI, Yoon C, Park MR, Lee D, Kook M-C, Lin J-X, Kang JH, Ashktorab H, Smoot DT, Yoon SS (2019) CDX1 expression induced by CagA-expressing Helicobacter pylori promotes gastric tumorigenesis. Mol Cancer Res 17(11):2169–2183

CAS  PubMed  Google Scholar 

Choreño-Parra JA, Dunlap MD, Swanson R, Jiménez-Álvarez LA, Muñoz-Torrico M, Guzmán-Beltrán S, Zúñiga J, Khader SA (2021) CXCL17 Is Dispensable during hypervirulent Mycobacterium tuberculosis HN878 infection in mice. ImmunoHorizons. 5:752–7599

Choreño-Parra JA, Jiménez-Álvarez LA, Ramírez-Martínez G, Sandoval-Vega M, Salinas-Lara C, Sánchez-Garibay C, Luna-Rivero C, Hernández-Montiel EM, Fernández-López LA, Cabrera-Cornejo MF (2021) CXCL17 is a specific diagnostic biomarker for severe pandemic influenza A (H1N1) that predicts poor clinical outcome. Front Immunol 12:633297

PubMed  PubMed Central  Google Scholar 

Choreño-Parra JA, Thirunavukkarasu S, Zúñiga J, Khader SA (2020) The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine. Cytokine Growth Factor Rev 53:53–62

PubMed  PubMed Central  Google Scholar 

Colobran R, Pujol-Borrell R, Armengol MP, Juan M (2007) The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity. Clin Experimental Immunol 148(2):208–217

CAS  Google Scholar 

Cosi C, Mannaioni G, Cozzi A, Carlà V, Sili M, Cavone L, Maratea D, Moroni F (2011) G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast. Neuropharmacology 60(7–8):1227–1231

CAS  PubMed  Google Scholar 

Dai C, Basilico P, Cremona TP, Collins P, Moser B, Benarafa C, Wolf M (2015) CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection. J Immunol 194(12):5980–5989

CAS  PubMed  Google Scholar 

Denisov SS (2021) CXCL17: The black sheep in the chemokine flock. Front Immunol :2811

Esposito R, Morello S, Vllahu M, Eletto D, Porta A, Tosco A (2017) Gastric TFF1 expression from acute to chronic Helicobacter infection. Front Cell Infect Microbiol 7:434

PubMed  PubMed Central  Google Scholar 

Fermin JM, Alam MM, Gu X, Asarkar A, Nathan C-A, Khandelwal AR (2021) CXCL17 as a prognostic biomarker for aggressive cutaneous squamous cell carcinoma. Cancer Res 81(13Supplement):647–647

Google Scholar 

Fujii Y, Yoshihashi K, Suzuki H, Tsutsumi S, Mutoh H, Maeda S, Yamagata Y, Seto Y, Aburatani H, Hatakeyama M (2012) CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proceedings of the National Academy of Sciences 109(50): 20584–20589

Gong F-h, Xiao X-q, Zhang X-p, Long L, Huang S, Wang X-s Z.-l. Shu and Y.-s. Yang (2019). Association between unstable angina and CXCL17: a new potential biomarker. Open Medicine 14(1):939–944

Guo YJ, Zhou YJ, Yang XL, Shao ZM, Ou ZL (2017) The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer. Biochem Biophys Res Commun 493(3):1159–1167

CAS  PubMed  Google Scholar 

Han M, Wang S, Fritah S, Wang X, Zhou W, Yang N, Ni S, Huang B, Chen A, Li G (2020) Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling. Brain 143(2):512–530

PubMed  Google Scholar 

Hao J, Gao X, Wang Y-p, Liu Q, Zhu H, Zhao S-j, Qin Q-h, Meng J, Li L-L, Lin S-C (2022) Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma. Anticancer Drugs 33(5):467–477

CAS  PubMed  Google Scholar 

Heinosalo T, Gabriel M, Kallio L, Adhikari P, Huhtinen K, Laajala T, Kaikkonen E, Mehmood A, Suvitie P, Kujari H (2018) Secreted frizzled-related protein 2 (SFRP2) expression promotes lesion proliferation via canonical WNT signaling and indicates lesion borders in extraovarian endometriosis. Hum Reprod 33(5):817–831

CAS  PubMed  Google Scholar 

Hernández-Ruiz M, Othy S, Herrera C, Nguyen HT, Arrevillaga‐Boni G, Catalan‐Dibene J, Cahalan MD, Zlotnik A (2019) Cxcl17–/– mice develop exacerbated disease in a T cell‐dependent autoimmune model. J Leukoc Biol 105(5):1027–1039

PubMed  Google Scholar 

Heuer F, Stürmer R, Heuer J, Kalinski T, Lemke A, Meyer F, Hoffmann W (2019) Different forms of TFF2, a lectin of the human gastric mucus barrier: In vitro binding studies. Int J Mol Sci 20(23):5871

CAS  PubMed Central  Google Scholar 

Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, Shiba F, Shiota M, Katou F, Saito T (2003) CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 170(3):1452–1461

CAS  PubMed  Google Scholar 

Hiraoka N, Yamazaki–Itoh R, Ino Y, Mizuguchi Y, Yamada T, Hirohashi S, Kanai Y (2011) CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology 140(1):310–321 e314

CAS  PubMed  Google Scholar 

Hoffmann W (2015) TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more. Int J Oncol 47(3):806–816

CAS  PubMed  Google Scholar 

Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson II K, Azam M, Hou Y-H (1999) Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 255(3):703–706

CAS  PubMed  Google Scholar 

Hsu Y-L, Yen M-C, Chang W-A, Tsai P-H, Pan Y-C, Liao S-H, Kuo P-L (2019) CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB. Breast Cancer Res 21(1):1–13

CAS  Google Scholar 

Hu J, Chen Y, Li X, Miao H, Li R, Chen D, Wen Z (2019) THUMPD3-AS1 is correlated with non-small cell lung cancer and regulates self-renewal through miR-543 and ONECUT2. OncoTargets Ther 12:9849

CAS  Google Scholar 

Ito T, Carson IV WF, Cavassani KA, Connett JM, Kunkel SL (2011) CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 317(5):613–619

CAS  PubMed  PubMed Central  Google Scholar 

Khandelwal AR, Alam MM, Moore-Medlin T, Savage HA, Nathan C-AO (2019) Role of the CXCL17-CXCR8 (GPR35) axis in cutaneous squamous cell carcinoma. Cancer Res 79(13Supplement):1969–1969

Google Scholar 

Khandelwal AR, Kandula RA, Alam MM, Fermin JM, Moore-Medlin T, DiGiovanni J, Nathan C-AO (2022) Targeting CXCL17 (CXC Motif Chemokine Ligand 17) inhibits cutaneous squamous cell carcinoma via modulating angiogenesis. Cancer Res 82(12Supplement):231–231

Google Scholar 

Khandelwal AR, Paralikar AA, Soleja RQ, Temple ZB, Robert MM, Alam M, Nathan C-AO (2020) CXCL17 modulates macrophage polarization and immune cell infiltrate in cutaneous squamous cell carcinoma. Cancer Res 80(16Supplement):3859–3859

Google Scholar 

Kim LC, Song L, Haura EB (2009) Src kinases as therapeutic targets for cancer. Nat reviews Clin Oncol 6(10):587–595

Google Scholar 

Ku C-Y, Wang Y-R, Lin H-Y, Lu S-C, Lin J-Y (2015) Corosolic acid inhibits hepatocellular carcinoma cell migration by targeting the VEGFR2/Src/FAK pathway. PLoS ONE 10(5):e0126725

PubMed  PubMed Central  Google Scholar 

Lee W-Y, Wang C-J, Lin T-Y, Hsiao C-L, Luo C-W (2013) CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor. Am J Physiology-Endocrinology Metabolism 304(1):E32–E40

CAS  Google Scholar 

Li L, Ji Y, Chen Y-C, Zhen Z-J (2021) MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma. Cytokine 141:155436

CAS  PubMed  Google Scholar 

Li L, Yan J, Xu J, Liu C-Q, Zhen Z-J, Chen H-W, Ji Y, Wu Z-P, Hu J-Y, Zheng L (2014) CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma. PLoS ONE 9(10):e110064

PubMed  PubMed Central  Google Scholar 

Li Y-z, Liu A-r, Liu S-y, Yan L-r, Yuan Y, Xu Q (2021) The Involvement of CXCL17-GPR35 in Gastric Cancer Initiation and Development.

Liu W, Xie X, Wu J (2020) Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17. Cell Oncol 43(2):311–320

CAS  Google Scholar 

Llopis M, Antolin M, Carol M, Borruel N, Casellas F, Martinez C, Espín-Basany E, Guarner F, Malagelada JR (2009) Lactobacillus casei downregulates commensals’ inflammatory signals in Crohn’s disease mucosa. Inflamm Bowel Dis 15(2):275–283

PubMed  Google Scholar 

Loose D, Van de Wiele C (2009) The immune system and cancer. Cancer Biother Radio 24(3):369–376

CAS  Google Scholar 

Luttrell L (2003) ‘Location, location, location’: activation and targeting of MAP kinases by G protein-coupled receptors. J Mol Endocrinol 30(2):117–126

CAS  PubMed